Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117558103 | 11755810 | 3 | F | 20151108 | 20160818 | 20151119 | 20160825 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-080830 | BRISTOL MYERS SQUIBB | 71.09 | YR | F | Y | 76.00000 | KG | 20160825 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117558103 | 11755810 | 1 | PS | ELIQUIS | APIXABAN | 1 | Oral | 10 MG, QD | 202155 | 10 | MG | QD | |||||||
117558103 | 11755810 | 2 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
117558103 | 11755810 | 3 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 DF, QD | 0 | 2 | DF | QD | |||||||
117558103 | 11755810 | 4 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
117558103 | 11755810 | 5 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | Oral | 2.5 MG, QD | 0 | 2.5 | MG | QD | |||||||
117558103 | 11755810 | 6 | C | IPRATROPIUM/ALBUTEROL | ALBUTEROLIPRATROPIUM | 1 | Respiratory (inhalation) | 1 DF, UNK | 0 | 1 | DF | ||||||||
117558103 | 11755810 | 7 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0.5 MG, QD | 0 | .5 | MG | QD | |||||||
117558103 | 11755810 | 8 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
117558103 | 11755810 | 9 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | QD | |||||||
117558103 | 11755810 | 10 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
117558103 | 11755810 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
117558103 | 11755810 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
117558103 | 11755810 | 13 | C | PRIMIDONE. | PRIMIDONE | 1 | Oral | QD | 0 | 150 | MG | QD | |||||||
117558103 | 11755810 | 14 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
117558103 | 11755810 | 15 | C | SLOW MAG /01486809/ | 2 | Oral | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
117558103 | 11755810 | 16 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 12.5 MG, QD | 0 | 12.5 | MG | QD | |||||||
117558103 | 11755810 | 17 | C | STIOLTO RESPIMAT | OLODATEROL HYDROCHLORIDETIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 2 DF, QD | 0 | 2 | DF | QD | |||||||
117558103 | 11755810 | 18 | C | TORSEMIDE. | TORSEMIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
117558103 | 11755810 | 19 | C | UNITHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 150 MG, QD | 0 | 150 | MG | QD | |||||||
117558103 | 11755810 | 20 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 12 MG, QD | Y | 0 | 12 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117558103 | 11755810 | 1 | Product used for unknown indication |
117558103 | 11755810 | 2 | Product used for unknown indication |
117558103 | 11755810 | 3 | Product used for unknown indication |
117558103 | 11755810 | 4 | Product used for unknown indication |
117558103 | 11755810 | 5 | Product used for unknown indication |
117558103 | 11755810 | 6 | Product used for unknown indication |
117558103 | 11755810 | 7 | Product used for unknown indication |
117558103 | 11755810 | 8 | Product used for unknown indication |
117558103 | 11755810 | 9 | Product used for unknown indication |
117558103 | 11755810 | 10 | Product used for unknown indication |
117558103 | 11755810 | 11 | Upper gastrointestinal haemorrhage |
117558103 | 11755810 | 13 | Product used for unknown indication |
117558103 | 11755810 | 14 | Product used for unknown indication |
117558103 | 11755810 | 15 | Hypomagnesaemia |
117558103 | 11755810 | 16 | Product used for unknown indication |
117558103 | 11755810 | 17 | Product used for unknown indication |
117558103 | 11755810 | 18 | Product used for unknown indication |
117558103 | 11755810 | 19 | Product used for unknown indication |
117558103 | 11755810 | 20 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117558103 | 11755810 | OT |
117558103 | 11755810 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117558103 | 11755810 | Contraindicated product administered | |
117558103 | 11755810 | Transfusion | |
117558103 | 11755810 | Upper gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117558103 | 11755810 | 1 | 20150906 | 0 | ||
117558103 | 11755810 | 2 | 2006 | 0 | ||
117558103 | 11755810 | 3 | 2014 | 0 | ||
117558103 | 11755810 | 4 | 1996 | 0 | ||
117558103 | 11755810 | 5 | 20151027 | 0 | ||
117558103 | 11755810 | 6 | 2015 | 0 | ||
117558103 | 11755810 | 7 | 2012 | 0 | ||
117558103 | 11755810 | 8 | 20150502 | 0 | ||
117558103 | 11755810 | 9 | 2009 | 0 | ||
117558103 | 11755810 | 10 | 1990 | 0 | ||
117558103 | 11755810 | 11 | 20151108 | 0 | ||
117558103 | 11755810 | 12 | 2012 | 0 | ||
117558103 | 11755810 | 13 | 2013 | 0 | ||
117558103 | 11755810 | 14 | 2000 | 0 | ||
117558103 | 11755810 | 15 | 20150401 | 0 | ||
117558103 | 11755810 | 16 | 2014 | 0 | ||
117558103 | 11755810 | 17 | 20150901 | 0 | ||
117558103 | 11755810 | 18 | 2014 | 0 | ||
117558103 | 11755810 | 19 | 20140902 | 0 | ||
117558103 | 11755810 | 20 | 20151108 | 20151109 | 0 |